Table 3.
Anti-FXa level
| Therapeutic dose (N = 19) | Intermediate dose (N = 23) | p value | |
|---|---|---|---|
| Anti-FXa activity | |||
| Anti-FXa within the expected range 0.2–0.5 U/mL | 8 (42.1) | 12 (52.2) | 0.520 |
| Out of expected range | |||
| Anti-FXa above the expected range | 9 (47.4) | 3 (13) | 0.015 |
| Anti-FXa below the expected range | 2 (10.5) | 8 (34.8) | 0.069 |
Values are shown as frequency (percentage).